These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 1697031
1. Identification and characterization of transcriptional arrest sites in exon 1 of the human adenosine deaminase gene. Chen Z, Harless ML, Wright DA, Kellems RE. Mol Cell Biol; 1990 Sep; 10(9):4555-64. PubMed ID: 1697031 [Abstract] [Full Text] [Related]
2. Sequence requirements for transcriptional arrest in exon 1 of the murine adenosine deaminase gene. Ramamurthy V, Maa MC, Harless ML, Wright DA, Kellems RE. Mol Cell Biol; 1990 Apr; 10(4):1484-91. PubMed ID: 1690842 [Abstract] [Full Text] [Related]
3. Sequence requirements for transcriptional arrest in exon 1 of the human adenosine deaminase gene. Chen Z, Innis JW, Sun MH, Wright DA, Kellems RE. Mol Cell Biol; 1991 Dec; 11(12):6248-56. PubMed ID: 1944287 [Abstract] [Full Text] [Related]
4. A heat-labile factor promotes premature 3' end formation in exon 1 of the murine adenosine deaminase gene in a cell-free transcription system. Innis JW, Kellems RE. Mol Cell Biol; 1991 Nov; 11(11):5398-409. PubMed ID: 1717827 [Abstract] [Full Text] [Related]
5. Functional analysis of a stable transcription arrest site in the first intron of the murine adenosine deaminase gene. Kash SF, Innis JW, Jackson AU, Kellems RE. Mol Cell Biol; 1993 May; 13(5):2718-29. PubMed ID: 8474437 [Abstract] [Full Text] [Related]
6. Molecular cloning of the murine adenosine deaminase gene from a genetically enriched source: identification and characterization of the promoter region. Ingolia DE, Al-Ubaidi MR, Yeung CY, Bigo HA, Wright D, Kellems RE. Mol Cell Biol; 1986 Dec; 6(12):4458-66. PubMed ID: 2432402 [Abstract] [Full Text] [Related]
7. Control of transcription arrest in intron 1 of the murine adenosine deaminase gene. Kash SF, Kellems RE. Mol Cell Biol; 1994 Sep; 14(9):6198-207. PubMed ID: 8065352 [Abstract] [Full Text] [Related]
9. Identification of transcription stop sites at the 5' and 3' ends of the murine adenosine deaminase gene. Maa MC, Chinsky JM, Ramamurthy V, Martin BD, Kellems RE. J Biol Chem; 1990 Jul 25; 265(21):12513-9. PubMed ID: 2373702 [Abstract] [Full Text] [Related]
10. Adenosine deaminase: characterization and expression of a gene with a remarkable promoter. Valerio D, Duyvesteyn MG, Dekker BM, Weeda G, Berkvens TM, van der Voorn L, van Ormondt H, van der Eb AJ. EMBO J; 1985 Feb 25; 4(2):437-43. PubMed ID: 3839456 [Abstract] [Full Text] [Related]
11. Cell type-specific transcriptional regulation of the human adenosine deaminase gene. Lattier DL, States JC, Hutton JJ, Wiginton DA. Nucleic Acids Res; 1989 Feb 11; 17(3):1061-76. PubMed ID: 2784203 [Abstract] [Full Text] [Related]
12. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing. Akeson AL, Wiginton DA, States JC, Perme CM, Dusing MR, Hutton JJ. Proc Natl Acad Sci U S A; 1987 Aug 11; 84(16):5947-51. PubMed ID: 3475710 [Abstract] [Full Text] [Related]
13. Structural and functional analysis of the murine adenosine deaminase gene. al-Ubaidi MR, Ramamurthy V, Maa MC, Ingolia DE, Chinsky JM, Martin BD, Kellems RE. Genomics; 1990 Aug 11; 7(4):476-85. PubMed ID: 2387582 [Abstract] [Full Text] [Related]
14. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases. Nakamuta M, Oka K, Krushkal J, Kobayashi K, Yamamoto M, Li WH, Chan L. J Biol Chem; 1995 Jun 02; 270(22):13042-56. PubMed ID: 7768898 [Abstract] [Full Text] [Related]
15. Normal and mutant human adenosine deaminase genes. Akeson AL, Wiginton DA, Hutton JJ. J Cell Biochem; 1989 Mar 02; 39(3):217-28. PubMed ID: 2651461 [Abstract] [Full Text] [Related]
16. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. Hirschhorn R, Tzall S, Ellenbogen A, Orkin SH. J Clin Invest; 1989 Feb 02; 83(2):497-501. PubMed ID: 2783588 [Abstract] [Full Text] [Related]
17. Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients. Berkvens TM, van Ormondt H, Gerritsen EJ, Khan PM, van der Eb AJ. Genomics; 1990 Aug 02; 7(4):486-90. PubMed ID: 1696926 [Abstract] [Full Text] [Related]
18. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene. Berkvens TM, Gerritsen EJ, Oldenburg M, Breukel C, Wijnen JT, van Ormondt H, Vossen JM, van der Eb AJ, Meera Khan P. Nucleic Acids Res; 1987 Nov 25; 15(22):9365-78. PubMed ID: 3684597 [Abstract] [Full Text] [Related]
19. Promoter escape by RNA polymerase II. A role for an ATP cofactor in suppression of arrest by polymerase at promoter-proximal sites. Dvir A, Conaway RC, Conaway JW. J Biol Chem; 1996 Sep 20; 271(38):23352-6. PubMed ID: 8798537 [Abstract] [Full Text] [Related]